REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Feb 07, 2024 | Sale | $950.35 | 8,037 | 7,637,954 | 59,956 | Feb 08, 2024, 04:02 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Feb 02, 2024 | Option Exercise | $636.29 | 53,463 | 34,017,937 | 82,769 | Feb 06, 2024, 04:08 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Dec 11, 2023 | Option Exercise | $844.09 | 725 | 611,965 | 52,019 | Dec 12, 2023, 04:05 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Dec 08, 2023 | Option Exercise | $843.79 | 809 | 682,626 | 51,891 | Dec 12, 2023, 04:05 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Aug 21, 2023 | Option Exercise | $587.89 | 88,335 | 51,931,006 | 103,100 | Aug 23, 2023, 04:03 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Aug 22, 2023 | Sale | $840.98 | 11,665 | 9,810,082 | 58,456 | Aug 23, 2023, 04:03 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Dec 09, 2022 | Option Exercise | $753.28 | 466 | 351,028 | 51,999 | Dec 13, 2022, 04:11 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Aug 05, 2022 | Sale | $612.61 | 23,782 | 14,569,134 | 76,401 | Aug 08, 2022, 04:11 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Aug 04, 2022 | Option Exercise | $417.21 | 166,218 | 69,347,483 | 147,795 | Aug 08, 2022, 04:11 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Dec 11, 2021 | Option Exercise | $664.34 | 753 | 500,248 | 53,130 | Dec 14, 2021, 04:08 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Dec 03, 2021 | Option Exercise | $364.93 | 122,852 | 44,832,048 | 101,309 | Dec 06, 2021, 04:10 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | May 08, 2020 | Option Exercise | $237.85 | 19,695 | 4,684,396 | 23,880 | May 11, 2020, 04:39 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | May 11, 2020 | Sale | $569.52 | 5,305 | 3,021,289 | 16,373 | May 11, 2020, 04:39 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Apr 14, 2020 | Sale | $521.07 | 5,497 | 2,864,307 | 16,875 | Apr 15, 2020, 04:17 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Apr 13, 2020 | Option Exercise | $220.66 | 20,661 | 4,559,148 | 24,459 | Apr 15, 2020, 04:17 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Feb 26, 2020 | Option Exercise | $199.78 | 39,651 | 7,921,391 | 36,380 | Feb 28, 2020, 04:40 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Feb 27, 2020 | Sale | $452.26 | 10,349 | 4,680,460 | 21,520 | Feb 28, 2020, 04:40 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Feb 12, 2020 | Option Exercise | $181.86 | 39,722 | 7,223,999 | 36,380 | Feb 14, 2020, 04:09 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Feb 13, 2020 | Sale | $400.66 | 10,278 | 4,117,958 | 17,356 | Feb 14, 2020, 04:09 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Nov 25, 2019 | Option Exercise | $168.48 | 15,994 | 2,694,623 | 32,455 | Nov 26, 2019, 04:29 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Nov 26, 2019 | Sale | $364.07 | 4,006 | 1,458,467 | 25,039 | Nov 26, 2019, 04:29 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Nov 08, 2019 | Sale | $338.52 | 7,364 | 2,492,888 | 29,719 | Nov 12, 2019, 04:05 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | May 13, 2019 | Option Exercise | $147.17 | 40,147 | 5,908,468 | 47,450 | May 15, 2019, 04:02 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | May 14, 2019 | Sale | $305.74 | 9,853 | 3,012,483 | 25,728 | May 15, 2019, 04:02 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | May 23, 2018 | Option Exercise | $126.49 | 42,065 | 5,320,744 | 58,709 | May 25, 2018, 04:03 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | May 24, 2018 | Sale | $295.09 | 11,407 | 3,366,092 | 31,973 | May 25, 2018, 04:03 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Jun 21, 2017 | Option Exercise | $207.51 | 31,694 | 6,576,774 | 43,950 | Jun 23, 2017, 04:09 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Jun 22, 2017 | Sale | $532.55 | 8,306 | 4,423,332 | 32,156 | Jun 23, 2017, 04:09 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Jun 15, 2017 | Sale | $468.45 | 8,567 | 4,013,177 | 32,017 | Jun 16, 2017, 04:36 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Jun 14, 2017 | Option Exercise | $187.64 | 32,023 | 6,008,636 | 44,245 | Jun 16, 2017, 04:36 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Jun 01, 2017 | Option Exercise | $311.17 | 18,276 | 5,686,949 | 30,814 | Jun 05, 2017, 04:52 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Jun 02, 2017 | Sale | $479.49 | 2,812 | 1,348,314 | 26,662 | Jun 05, 2017, 04:52 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Dec 16, 2015 | Option Exercise | $52.03 | 1,921 | 99,950 | 27,594 | Dec 18, 2015, 04:27 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Nov 09, 2015 | Sale | $560.05 | 22,101 | 12,377,559 | 34,436 | Nov 09, 2015, 05:10 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Nov 05, 2015 | Option Exercise | $226.05 | 157,899 | 35,693,710 | 97,029 | Nov 09, 2015, 05:10 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | EVP Research and Development | Nov 06, 2015 | Sale | $563.00 | 20,000 | 11,260,068 | 54,575 | Nov 09, 2015, 05:10 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Dec 16, 2014 | Option Exercise | $30.63 | 3,264 | 99,976 | 6,541 | Dec 18, 2014, 04:25 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Nov 21, 2014 | Sale | $415.16 | 3,107 | 1,289,902 | 5,477 | Nov 24, 2014, 04:15 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Nov 24, 2014 | Sale | $409.78 | 2,200 | 901,523 | 3,690 | Nov 24, 2014, 04:15 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Nov 18, 2014 | Option Exercise | $233.67 | 28,207 | 6,591,263 | 30,284 | Nov 20, 2014, 04:14 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Aug 11, 2014 | Sale | $339.96 | 11,646 | 3,959,204 | 23,556 | Aug 11, 2014, 04:04 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Aug 06, 2014 | Option Exercise | $137.60 | 55,513 | 7,638,374 | 48,527 | Aug 08, 2014, 04:49 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Aug 07, 2014 | Sale | $340.49 | 741 | 252,304 | 27,390 | Aug 08, 2014, 04:49 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Aug 08, 2014 | Sale | $340.64 | 2,100 | 715,340 | 25,373 | Aug 08, 2014, 04:49 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Feb 13, 2014 | Sale | $318.82 | 22,612 | 7,209,136 | 45,203 | Feb 13, 2014, 06:32 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Feb 12, 2014 | Option Exercise | $132.46 | 86,484 | 11,455,722 | 64,391 | Feb 13, 2014, 06:32 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Dec 18, 2013 | Option Exercise | $21.25 | 4,705 | 99,981 | 24,391 | Dec 19, 2013, 09:49 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Dec 16, 2013 | Option Exercise | $272.73 | 9,302 | 2,536,935 | 19,686 | Dec 17, 2013, 04:09 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | May 10, 2013 | Option Exercise | $112.84 | 87,838 | 9,911,361 | 104,426 | May 14, 2013, 11:51 AM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | May 13, 2013 | Sale | $276.88 | 23,038 | 6,378,805 | 58,648 | May 14, 2013, 11:51 AM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res and Devel Sciences | Dec 14, 2012 | Option Exercise | $179.13 | 8,386 | 1,502,184 | 43,036 | Dec 18, 2012, 11:31 AM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res and Devel Sciences | Dec 17, 2012 | Option Exercise | $16.80 | 5,952 | 99,994 | 48,988 | Dec 18, 2012, 11:31 AM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res and Devel Sciences | Nov 30, 2012 | Option Exercise | $124.14 | 26,665 | 3,310,107 | 51,422 | Dec 03, 2012, 04:20 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res and Devel Sciences | Nov 20, 2012 | Option Exercise | $70.35 | 84,643 | 5,954,605 | 104,219 | Nov 21, 2012, 03:50 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res and Devel Sciences | Nov 21, 2012 | Sale | $174.30 | 24,357 | 4,245,442 | 74,278 | Nov 21, 2012, 03:50 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Aug 29, 2012 | Sale | $145.74 | 16,884 | 2,460,647 | 74,505 | Aug 30, 2012, 12:04 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Aug 28, 2012 | Option Exercise | $67.25 | 63,116 | 4,244,801 | 99,121 | Aug 30, 2012, 12:04 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res & Dev Sciences | Jun 18, 2012 | Option Exercise | $55.59 | 151,247 | 8,407,614 | 154,200 | Jun 20, 2012, 11:12 AM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res & Dev Sciences | Jun 19, 2012 | Sale | $116.02 | 38,911 | 4,514,593 | 73,184 | Jun 20, 2012, 11:12 AM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Feb 14, 2012 | Sale | $67.99 | 110,120 | 7,486,838 | 140,323 | Feb 15, 2012, 04:52 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Feb 15, 2012 | Sale | $107.82 | 21,082 | 2,273,036 | 61,146 | Feb 15, 2012, 04:52 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Feb 13, 2012 | Option Exercise | $44.91 | 102,130 | 4,586,505 | 122,355 | Feb 15, 2012, 04:52 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Dec 14, 2011 | Option Exercise | $51.18 | 8,411 | 430,475 | 59,121 | Dec 15, 2011, 04:05 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Nov 14, 2011 | Option Exercise | $11.64 | 17,182 | 199,998 | 67,532 | Nov 15, 2011, 05:03 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Sep 06, 2011 | Option Exercise | $31.77 | 131,876 | 4,190,056 | 133,168 | Sep 08, 2011, 04:24 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Research and Development S | Sep 07, 2011 | Sale | $69.74 | 33,760 | 2,354,376 | 82,910 | Sep 08, 2011, 04:24 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res and Dev Sciences | Apr 04, 2011 | Option Exercise | $25.58 | 150,501 | 3,849,531 | 142,658 | Apr 05, 2011, 04:42 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res and Dev Sciences | Apr 05, 2011 | Sale | $46.10 | 34,115 | 1,572,656 | 73,265 | Apr 05, 2011, 04:42 PM |
REGN | | REGENERON PHARMACEUTICALS INC | STAHL NEIL | SVP Res and Dev Sciences | Mar 30, 2011 | Option Exercise | $29.00 | 15,384 | 446,136 | 58,042 | Mar 31, 2011, 05:28 PM |